Explore more publications!

Puerto Rico Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.

Press releases published on December 9, 2025

Cority Collaborates with Google Cloud to Advance AI in EHS and Sustainability
A.D.A.M. Innovations Announces the Launch of ALUNAÉ
Mavenir confirma su estrategia de reenfoque en el núcleo móvil y su visión de IA con un equipo de liderazgo ampliado para acelerar la estrategia de redes nativas de IA
Mavenir confirme sa stratégie de recentrage sur son segment Mobile Core et sa vision de l’IA avec une équipe de direction élargie afin d’accélérer sa stratégie de réseau IA native
Mavenir מאשרת מיקוד מחדש של האסטרטגיה בליבת המובייל ובחזון הבינה המלאכותית עם צוות הנהלה מורחב להאצת אסטרטגיית הרשת המבוססת על בינה מלאכותית
Mavenir Mengonfirmasi Strategi Fokus Ulang pada Inti Jaringan Seluler dan Visi AI dengan Perluasan Tim Pemimpin untuk Mempercepat Penerapan Strategi Jaringan Berbasis AI
Mavenir, AI 네이티브 네트워크 전략 위해 경영진 확대 재편하며 모바일 코어와 AI 비전에 다시 전략적 초점 맞춘다
Mavenir Confirma Estratégia de Concentração no Mobile Core e no AI Vision com Equipe de Liderança Expandida para Acelerar Estratégia de Rede Nativa de IA
Mavenir ยืนยันจะใช้กลยุทธ์การเปลี่ยนทิศทางขององค์กรด้าน Mobile Core และวิสัยทัศน์เกี่ยวกับ AI พร้อมขยายทีมผู้นำเพื่อเร่งวางกลยุทธ์เครือข่าย AI แบบเนที…
Mavenir 宣布将重新聚焦于移动核心网络与 AI 愿景的战略方向,并通过扩充领导团队,加速推进 AI 原生网络战略
Mavenir 確認調整策略眾焦流動核心及人工智能願景,並擴充領導團隊加快推動全人工智能原生網絡策略
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
Regula’s Database Expands to 16,000 ID Templates, as New 2026 Passport Standards Emerge
Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
Sesen Launches TrialS, a Next Generation Platform for Regulatory, Clinical, and Labeling Translation Validation
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism
Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
Codetta Bio™ Expands Global Commercial Leadership to Accelerate Worldwide Adoption of the Concerto™ System
Payscale Identifies the Fastest Growing and Most At-Risk Jobs Heading Into 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions